Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Our new specialty pharmacy vendor, Curant, dispenses our Products and performs related pharmacy and patient support services, including the collection of payments from insurers representing more than 99 percent of our revenue.”
FILING10-K0001628280-26-011091cik 0001088856
“From 2017 until 2025, we used an exclusive specialty pharmacy vendor, Optime Care, Inc. ("Optime") and a specialty distributor to distribute our Products and provide logistical support to physicians and patients.”
FILING10-K0001628280-26-011091cik 0001088856
“In collaboration with the Paris-based academic research cooperative ARCAGY-GINECO, we will initiate, in the first quarter of 2026, a Phase 2 trial, STELLA, in 50 patients with cervical cancer, who have received one or two prior lines of therapy.”
FILING10-K0001628280-26-011091cik 0001088856
“Medpace Research is helping us conduct our MOMENTUM and MONARCH trials.”
FILING10-K0001628280-26-011091cik 0001088856
“Syneos Health is helping us conduct our ROSELLA and BELLA trials.”
FILING10-K0001628280-26-011091cik 0001088856
“Patents we have licensed from the University of Chicago cover the use of relacorilant combined with anticancer agents, including enzalutamide, to treat patients with this disease.”
FILING10-K0001628280-26-011091cik 0001088856
Watchlist prices, news filtered to it, and its next report on your desk.
Corcept Therapeutics Inc has 6 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Corcept Therapeutics Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Corcept Therapeutics Inc. Customers appear here when Corcept Therapeutics Inc names them, or when a company names Corcept Therapeutics Inc as a supplier in its own annual report.
CORT (Corcept Therapeutics Inc) has 6 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Corcept Therapeutics Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 110.60 · gapped above the open, then crossed back over prior close. High/low 111.06 at 7:15 am ET, 109.79 at 2:45 pm ET.